Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06820463 |
| Title | A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AbbVie |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Hope And Healing Cancer Services /ID# 271562 | RECRUITING | Hinsdale | Illinois | 60521 | United States | Details |
| Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646 | RECRUITING | Omaha | Nebraska | 68130 | United States | Details |
| Rambam Health Care Campus /ID# 268006 | RECRUITING | Haifa | H_efa | 3525408 | Israel | Details |